Saitama, Japan

Tamio Hikosaka

This inventor holds 1 USPTO granted patent. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tamio Hikosaka. Retrieved from https://idiyas.com/inventor/tamio-hikosaka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tamio Hikosaka: Innovator in Pharmaceutical Formulations

Introduction

Tamio Hikosaka is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled-release formulations. His innovative work has led to the creation of a unique pharmaceutical formulation that enhances the delivery of active substances in the gastrointestinal tract.

Latest Patents

Hikosaka holds a patent for a "Controlled-release multiple units pharmaceutical formulation." This invention involves a granulation product that incorporates a release-controlling agent mixed with a physiologically active substance and units-forming substances. The resulting granules are designed to gradually release the active substance without disintegration, providing a more effective therapeutic effect.

Career Highlights

Hikosaka has been associated with Yamanouchi Pharmaceutical Company Ltd., where he has contributed to various research and development projects. His expertise in pharmaceutical formulations has been instrumental in advancing the company's product offerings.

Collaborations

Throughout his career, Hikosaka has collaborated with esteemed colleagues, including Muneo Fukui and Kouji Tomuro. These partnerships have fostered innovation and have been crucial in the development of new pharmaceutical technologies.

Conclusion

Tamio Hikosaka's work in controlled-release pharmaceutical formulations exemplifies the impact of innovative thinking in medicine. His contributions continue to influence the field and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…